Biopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight Partners
March 23, 2023 08:46 ET
|
The Insight Partners
New York, March 23, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Biopharmaceuticals Market Size, Share, Trends, Growth and Report Forecasts to 2028 - COVID-19 Impact and Global...
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
March 21, 2023 16:05 ET
|
Telesis Bio
-- Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 -- BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21 SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Telesis Bio...
‘Negative Evidence’ on COVID-19 Vaccines and Cancer Reviewed in the Journal of American Physicians and Surgeons (AAPS)
March 21, 2023 11:32 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 21, 2023 (GLOBE NEWSWIRE) -- Given the dread that the thought of cancer inspires, and anecdotal reports of cancer manifesting soon after a COVID-19 vaccination, the lack of...
Lyophilization Equipment Market Report 2023: Growing Technological Advancements in Equipment Bolsters Sector
March 15, 2023 07:33 ET
|
Research and Markets
Dublin, March 15, 2023 (GLOBE NEWSWIRE) -- The "Lyophilization Equipment Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.The lyophilization...
Telesis Bio to Present at RNA Leaders Europe Congress
March 14, 2023 06:00 ET
|
Telesis Bio
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their...
Dyadic Provides Phase 1 Clinical Trial Update for its DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
March 07, 2023 08:30 ET
|
Dyadic International, Inc.
Dosing of all patients was completed at the end of February No Serious Adverse Events (SAE’s) have been reported Phase 1 clinical initial safety and antibody response update expected in Q2, 2023 ...
Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends
March 03, 2023 00:27 ET
|
Novotech
SINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar with Endpoints...
Plasmid DNA Manufacturing Global Market Report 2023: Inorganic Growth Strategies Continue to Bolster Sector Expansion
February 28, 2023 07:38 ET
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Plasmid DNA Manufacturing Market, By Product Type, By Grade, By Application, By Manufacturing Type, By Development Phase, By Region - Size, Share,...
mRNA Manufacturing and Synthesis Services Market worth $22.6 Billion by 2031 Driven by Increasing Number of Clinical Trials | InsightAce Analytic
February 21, 2023 10:29 ET
|
InsightAce Analytic Pvt. LTd.
Pune, Feb. 21, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on “Global mRNA Manufacturing and Synthesis Services Market (3rd Edition) –...
Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation
February 16, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the availability of its BioXp® Select...